May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
January 2026
The global radiopharmaceutical CDMO market size was evaluated at USD 3.24 billion in 2025 and is predicted to hit around USD 8.50 billion by 2035, growing at a CAGR of 10.12%.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
July 2026
The global pharmaceutical packaging market size reached USD 159.29 billion in 2025 and is projected to hit around USD 367.88 billion by 2035 with a notable CAGR of 8.73%
July 2026
The pharmaceutical packaging equipment market size is estimated to hit around USD 18.32 billion by 2034 from USD 10.06 billion in 2025 with a notable CAGR of 7.02%.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global pharmaceutical grade sodium chloride market size is estimated to hit around USD 6.39 billion by 2035 increasing from USD 4.72 billion in 2025, with a CAGR of 3.08%.
July 2026
The tech-enabled pharmaceutical facilities market leverages smart technologies to optimize operations, reduce costs, and modernize pharmaceutical production.
July 2026
The europe nutraceuticals market size was estimated at USD 104.77 billion in 2025 and is expected to hit around USD 204.38 billion by 2035, growing at a CAGR of 6.91% from 2026 to 2035.
July 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
July 2026
The global pharmaceutical capsule filling machines market is growing as demand rises for efficient, high-speed production of oral solid dosage forms.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global pharmaceutical inspection machines market size is anticipated at USD 1.18 billion in 2025 and is predicted to hit around USD 3.05 billion by 2035, growing at a CAGR of 9.96%.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global pharmaceutical market size is estimated to hit nearly USD 3.20 trillion by 2035, up from USD 1.77 trillion in 2025, expanding at a solid CAGR of 6.10% from 2026 to 2035.
June 2026
The US pharmaceutical stability and storage services market size was evaluated at USD 1.66 billion in 2025 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 5.81%.
June 2026
The global senolytics and anti-aging pharmaceuticals market size was estimated at USD 4.50 billion in 2025 and is expected to hit around USD 9.31 billion by 2035, growing at a CAGR of 7.54%.
June 2026
The global pharmaceutical excipients market size is evaluated at USD 9.31 billion in 2025 and is expected to surpass USD 16.14 billion by 2035, with a CAGR of 5.66%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The US pharmaceutical excipients market size was evaluated at USD 3.08 billion in 2025 and is predicted to hit around USD 5.58 billion by 2035, growing at a CAGR of 6.12%.
June 2026
The global liquid filtration for pharmaceutical market is growing as demand rises for sterile drug manufacturing and contamination control.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The US active pharmaceutical ingredients market size was evaluated at USD 41.77 billion in 2025 and is predicted to hit around USD 79.80 billion by 2035, growing at a CAGR of 6.69%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com